Research and diagnostic of Malian, infectious and rare metabolic diseases based on MDI TOF technology (Q2727791): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
Recherche et diagnostic des maladies malignes, infectieuses et métaboliques rares sur la base de la technologie MALDI TOF | |||
Revision as of 09:44, 26 November 2021
Project Q2727791 in Croatia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Research and diagnostic of Malian, infectious and rare metabolic diseases based on MDI TOF technology |
Project Q2727791 in Croatia |
Statements
13,709,670.59 Croatian kuna
0 references
16,129,024.22 Croatian kuna
0 references
85.0 percent
0 references
28 May 2018
0 references
1 October 2019
0 references
Klinički bolnički centar Osijek
0 references
Q2758254 (Deleted Item)
0 references
45°33'17.86"N, 18°41'43.84"E
0 references
31000
0 references
Projektom će se riješiti problemi prijavitelja vezani uz nedostatne tehnološke kapacitete Odjela za kliničku kemiju KBC-a Osijek te postići cilj koji se odnosi na unapređenje znanstvene izvrsnosti u sektoru biomedicine i zdravstva u RH uvođenjem MALDI TOF MS tehnologije. Realizacija projekta zadovoljit će potrebe ciljnih skupina, dok će se rezultati istraživanja preusmjeriti na pružanje potpore gospodarstvu, prije svega osiguranicima HZZO-a, dijagnostičkoj i farmaceutskoj industriji. Dodatno, društvena vrijednost realizacije projekta je unaprijeđena zdravstvena zaštita i nastavna djelatnosti. (Croatian)
0 references
The project will address the applicants’ problems linked to the lack of technological capacities in the KWC Unit for Clinical Chemistry, and achieve the objective of improving scientific excellence in the biomedical and health sector in Croatia through the introduction of MalDI TOF MS technologies. The realisation of the project will meet the target group needs, while the results of the research will be redirected to supporting the economy, notably by HZZO, the diagnostic and pharmaceutical industry. In addition, the social value of the realisation of the project has improved health care and teaching activities. (English)
3 June 2021
0 references
Identifiers
KK.01.1.1.02.0015
0 references